BLOOD-PRESSURE AND MORTALITY AMONG MEN WITH PRIOR MYOCARDIAL-INFARCTION

被引:176
作者
FLACK, JM
NEATON, J
GRIMM, R
SHIH, J
CUTLER, J
ENSRUD, K
MACMAHON, S
机构
[1] UNIV MINNESOTA, SCH PUBL HLTH, DIV BIOSTAT, MINNEAPOLIS, MN USA
[2] UNIV MINNESOTA, SCH MED, DIV CARDIOL, MINNEAPOLIS, MN USA
[3] NHLBI, DIV EPIDEMIOL & CLIN APPLICAT, BETHESDA, MD 20892 USA
[4] UNIV MINNESOTA, VET ADM MED CTR, GEN MED SECT, MINNEAPOLIS, MN USA
[5] UNIV AUCKLAND, DEPT MED, CLIN TRIALS RES UNIT, AUCKLAND, NEW ZEALAND
关键词
BLOOD PRESSURE; MYOCARDIAL INFARCTION; HEART DISEASES; MORTALITY;
D O I
10.1161/01.CIR.92.9.2437
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The purpose of the present study was to describe the relation between blood pressure (systolic [SEP] and diastolic [DBP]) and death from coronary heart disease (CHD) and all causes for men with a history of myocardial infarction (MI). Methods and Results The study cohort consisted of men aged 35 to 57 years screened for the Multiple Risk Factor Intervention Trial (MRFIT) in 1973 through 1975 and followed for survival for an average of 16 years through 1990. There were 5362 men who reported prior hospitalization for a heart attack of at least 2 weeks' duration at the initial screening of MRFIT. There was a J-shaped relation between SEP and DBP with both CHD and all-cause mortality during the first 2 years of follow-up in older (age, 45 to 57 years) men only. Risk nadirs for SEP were 152 and 145 mm Hg, respectively, for CHD death and air-cause mortality; corresponding DBP risk nadirs were 94 and 90 mm Hg. After the first 2 years, there was a positive association between SEP and death from CHD and all causes. By 15 years, cumulative CHD mortality percentages for men with screening SEP <120, 120 to 139, 140 to 159, and greater than or equal to 160 mm Hg were 19.7%, 21.3%, 27.5%, and 32.0%, respectively. When deaths only after year 2 were considered, although the linear DBP coefficient was significant, the quadratic term for DBP was no longer significant (P>.05). However, the relation still appeared J-shaped as cumulative mortality for those with DBP <70, 70 to 79, 80 to 89, 90 to 99, and greater than or equal to 100 mm Hg was 24.3%, 20.8%, 21.1%, 25.5%, and 29.7%, respectively. When the joint relation of SEP and DBP was considered, there were no survival differences among the four cohorts (SEP greater than or equal to 140 and DBP <80, SEP greater than or equal to 140 and DBP greater than or equal to 80, SEP greater than or equal to 140 and DBP <80, and SEP greater than or equal to 140 and DBP greater than or equal to 80) during the first 2 years. After 2 years, both CHD and all-cause mortality rates were approximately 40% higher for participants with SEP greater than or equal to 140 mm Hg versus <140 mm Hg regardless of DBP level (<80 or greater than or equal to 80 mm Hg). Conclusions In this large cohort of men with prior MI, the association of SEP and DBP with CHD and all-cause mortality varied over the 16-year follow-up period. During early followup, in older men only, J- or U-shaped relations were evident. However, after 2 years, these same relations had become positive and graded. Given the substantial excess mortality risk in this cohort associated with high blood pressure, particularly SEP, efforts to gradually lower blood pressure should receive high priority among hypertensive men with prior MI.
引用
收藏
页码:2437 / 2445
页数:9
相关论文
共 41 条
[1]   TREATMENT-INDUCED BLOOD-PRESSURE REDUCTION AND THE RISK OF MYOCARDIAL-INFARCTION [J].
ALDERMAN, MH ;
OOI, WL ;
MADHAVAN, S ;
COHEN, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (07) :920-924
[2]  
[Anonymous], 1985, J Hypertens, V3, P379
[3]  
[Anonymous], 1991, JAMA, V265, P3255
[4]   EFFECTS OF TREATMENT ON MORBIDITY IN HYPERTENSION - RESULTS IN PATIENTS WITH DIASTOLIC BLOOD PRESSURES AVERAGING 115 THROUGH 129 MM HG [J].
不详 .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (11) :1028-&
[5]  
[Anonymous], 1970, JAMA, V213, P1143
[6]  
CANNER PL, 1974, AM J EPIDEMIOL, V100, P529
[7]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[8]   RANDOMIZED TRIAL OF TREATMENT OF HYPERTENSION IN ELDERLY PATIENTS IN PRIMARY CARE [J].
COOPE, J ;
WARRENDER, TS .
BRITISH MEDICAL JOURNAL, 1986, 293 (6555) :1145-1151
[9]   THE RELATION BETWEEN DEGREE OF BLOOD-PRESSURE REDUCTION AND MORTALITY AMONG HYPERTENSIVES IN THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM [J].
COOPER, SP ;
HARDY, RJ ;
LABARTHE, DR ;
HAWKINS, CM ;
SMITH, EO ;
BLAUFOX, MD ;
COOPER, CJ ;
ENTWISLE, G ;
MAXWELL, MH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 127 (02) :387-403
[10]   CORONARY FLOW RESERVE AND THE J-CURVE RELATION BETWEEN DIASTOLIC BLOOD-PRESSURE AND MYOCARDIAL-INFARCTION [J].
CRUICKSHANK, JM .
BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6658) :1227-1230